These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3002708)

  • 21. Effects of sodium nitroprusside (MR7S1) and nitroglycerin on the systemic, renal, cerebral, and coronary circulation of dogs anesthetized with enflurane.
    Hamaguchi M; Ishibashi T; Katsumata N; Mitomi A; Imai S
    Cardiovasc Drugs Ther; 1992 Dec; 6(6):611-22. PubMed ID: 1292581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylxanthines augment the renin response to suprarenal-aortic constriction.
    Deray G; Branch RA; Jackson EK
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):690-6. PubMed ID: 2570368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
    Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
    J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs.
    Zhao G; Linke A; Xu X; Ochoa M; Belloni F; Belardinelli L; Hintze TH
    J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthine derivatives in the heart: blessed or cursed?
    Szentmiklósi AJ; Cseppentō A; Gesztelyi R; Zsuga J; Körtvély A; Harmati G; Nánási PP
    Curr Med Chem; 2011; 18(24):3695-706. PubMed ID: 21774759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.
    Vials A; Burnstock G
    Br J Pharmacol; 1993 Jun; 109(2):424-9. PubMed ID: 8358543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microcalorimetric studies on the effect of adenosine receptor agonists and xanthine derivatives on overall metabolism in human platelets.
    Edvinsson L; Ikomi-Kumm J; Monti M
    Br J Clin Pharmacol; 1986 Dec; 22(6):685-9. PubMed ID: 3567015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation.
    Edlund A; Sollevi A
    Acta Physiol Scand; 1995 Nov; 155(3):303-11. PubMed ID: 8619329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of endogenous adenosine as a modulator of the renin response to salt restriction.
    Kuan CJ; Wells JN; Jackson EK
    Nephrologie; 1987; 8(6):283-6. PubMed ID: 3330576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and physiological effects of xanthines in nonhuman primates.
    Howell LL; Coffin VL; Spealman RD
    Psychopharmacology (Berl); 1997 Jan; 129(1):1-14. PubMed ID: 9122357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between adenosine and flow-induced dilation in coronary microvascular network.
    Liao JC; Kuo L
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1571-81. PubMed ID: 9139938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
    Fredholm BB; Lindgren E
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K+ATP channels and adenosine are not necessary for coronary autoregulation.
    Stepp DW; Kroll K; Feigl EO
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1299-308. PubMed ID: 9321819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine: an endogenous modulator of hippocampal noradrenaline release.
    Jackisch R; Fehr R; Hertting G
    Neuropharmacology; 1985 Jun; 24(6):499-507. PubMed ID: 2991802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.
    Randall MD; Ujiie H; Griffith TM
    Br J Pharmacol; 1994 May; 112(1):49-54. PubMed ID: 8032661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of adenosine-induced renal vasodilatation in hypertensive patients.
    Wierema TK; Houben AJ; Kroon AA; Postma CT; Koster D; van Engelshoven JM; Smits P; de Leeuw PW
    J Hypertens; 2005 Sep; 23(9):1731-6. PubMed ID: 16093919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs.
    Tayama S; Okumura K; Matsunaga T; Tsunoda R; Tabuchi T; Iwasa A; Yasue H
    Jpn Circ J; 1998 May; 62(5):371-8. PubMed ID: 9626906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation.
    Cason BA; Shubayev I; Hickey RF
    Anesthesiology; 1994 Nov; 81(5):1245-55; discussion 27A-28A. PubMed ID: 7978484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypotensive and renal vasodilator effects of carbocyclic adenosine (aristeromycin) in anesthetized spontaneously hypertensive rats.
    Dunham EW; Vince R
    J Pharmacol Exp Ther; 1986 Sep; 238(3):954-9. PubMed ID: 3018227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.